CLINICAL_TRIALS
trial_result
· 2020-11-04
Clinical Trial Update: SYL040012, Treatment for Open Angle Glaucoma [Phase 2]
Summary
Phase 2 trial update for SYL040012 in open angle glaucoma and ocular hypertension has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sylentis, S.A. | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-11-04